|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 35/17 | |
| A61K 35/15 | |||
| A61P 35/00 |
| (11) | Patento numeris | 3294304 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 16724230.4 |
| Europos patento paraiškos padavimo data | 2016-05-11 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-03-21 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-01-29 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2016/031784 |
| Data | 2016-05-11 |
| (87) | Numeris | WO 2016/183153 |
| Data | 2016-11-17 |
| (30) | Numeris | Data | Šalis |
| 201562160549 P | 2015-05-12 | US |
| (72) |
O`REILLY, Richard, John, US
PROCKOP, Susan Elizabeth, US
HASAN, Aisha Nasreen, US
DOUBROVINA, Ekaterina, US
|
| (73) |
Memorial Sloan Kettering Cancer Center,
1275 York Avenue, New York, NY 10065,
US
|
| (54) | METHODS OF TREATING EPSTEIN-BARR VIRUS-ASSOCIATED LYMPHOPROLIFERATIVE DISORDERS BY T CELL THERAPY |
| METHODS OF TREATING EPSTEIN-BARR VIRUS-ASSOCIATED LYMPHOPROLIFERATIVE DISORDERS BY T CELL THERAPY |